In Vivo CRO Market 2027 By Specimen Type, Study Type, Indication and Geography | The Insight Partners

In Vivo CRO Market to 2027 - Global Analysis and Forecasts By Specimen Type (Rodent and Non-Rodent); Study Type (Non GLP and GLP); Indication (Autoimmune/ Inflammatory Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Other Indications), and Geography

Report Code: TIPRE00007238 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

In vivo CRO refers to the preclinical testing performed for preclinical testing of disease pathology and drug discovery. In vivo CROs provide information regarding the collection and investigation of data for the development of new drugs for the treatment of various indications such as diabetes, cancer, autoimmune disorders, and others.

MARKET DYNAMICS

The in vivo CRO market is anticipated to grow in the forecast, owing to rising price competition and requirement to reduce cost coupled with a rise in the demand for advanced products. In addition, changing regulatory policies and the increase in chronic medical conditions is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "In Vivo CRO Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in vivo CRO market with detailed market segmentation by specimen type, study type, indication, and geography. The in vivo CRO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in vivo CRO market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The in vivo CRO market is segmented on the basis of specimen type, study type and indication. Based on specimen type the market is segmented as, rodent and non-rodent. On the basis of study type the market is categorized as, non GLP and GLP. Also, based on indication, the market is segmented as, autoimmune/ inflammatory conditions, pain management, oncology, CNS conditions, diabetes, obesity, and other indications.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in vivo CRO market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The in vivo CRO market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting in vivo CRO market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the in vivo CRO market in these regions.

MARKET PLAYERS


The report covers key developments in the in vivo CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in vivo CRO market are anticipated to have lucrative growth opportunities in the future with the rising demand for in vivo CRO market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.

The report also includes the profiles of key in vivo CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  American Preclinical Services, LLC.
  •  Charles River
  •  Covance Inc.
  •  GVK Biosciences Private Limited
  •  Iris Pharma
  •  MELIOR DISCOVERY
  •  Pronexus Analytical AB
  •  Syneos Health
  •  Washington Biotechnology, Inc.
  •  WuXi AppTec
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 In Vivo CRO Market - By Specimen Type
1.3.2 In Vivo CRO Market - By Study Type
1.3.3 In Vivo CRO Market - By Indication
1.3.4 In Vivo CRO Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. IN VIVO CRO MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. IN VIVO CRO MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. IN VIVO CRO MARKET - GLOBAL MARKET ANALYSIS
6.1. IN VIVO CRO - GLOBAL MARKET OVERVIEW
6.2. IN VIVO CRO - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2027 - SPECIMEN TYPE
7.1. OVERVIEW
7.2. SPECIMEN TYPE MARKET FORECASTS AND ANALYSIS
7.3. RODENT
7.3.1. Overview
7.3.2. Rodent Market Forecast and Analysis
7.3.3. Rats Market
7.3.3.1. Overview
7.3.3.2. Rats Market Forecast and Analysis
7.3.4. Mice Market
7.3.4.1. Overview
7.3.4.2. Mice Market Forecast and Analysis
7.3.5. Other Rodents Market
7.3.5.1. Overview
7.3.5.2. Other Rodents Market Forecast and Analysis
7.4. NON-RODENT
7.4.1. Overview
7.4.2. Non-Rodent Market Forecast and Analysis
7.4.3. Hamsters Market
7.4.3.1. Overview
7.4.3.2. Hamsters Market Forecast and Analysis
7.4.4. Guinea Pigs Market
7.4.4.1. Overview
7.4.4.2. Guinea Pigs Market Forecast and Analysis
7.4.5. Gerbils Market
7.4.5.1. Overview
7.4.5.2. Gerbils Market Forecast and Analysis
7.4.6. Other Non-Rodents Market
7.4.6.1. Overview
7.4.6.2. Other Non-Rodents Market Forecast and Analysis

8. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2027 - STUDY TYPE
8.1. OVERVIEW
8.2. STUDY TYPE MARKET FORECASTS AND ANALYSIS
8.3. NON GLP
8.3.1. Overview
8.3.2. Non GLP Market Forecast and Analysis
8.3.3. In House Market
8.3.3.1. Overview
8.3.3.2. In House Market Forecast and Analysis
8.3.4. Outsourcing Market
8.3.4.1. Overview
8.3.4.2. Outsourcing Market Forecast and Analysis
8.4. GLP
8.4.1. Overview
8.4.2. GLP Market Forecast and Analysis
8.4.3. In House Market
8.4.3.1. Overview
8.4.3.2. In House Market Forecast and Analysis
8.4.4. Outsourcing Market
8.4.4.1. Overview
8.4.4.2. Outsourcing Market Forecast and Analysis

9. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. AUTOIMMUNE/ INFLAMMATORY CONDITIONS
9.3.1. Overview
9.3.2. Autoimmune/ Inflammatory Conditions Market Forecast and Analysis
9.4. PAIN MANAGEMENT
9.4.1. Overview
9.4.2. Pain Management Market Forecast and Analysis
9.5. ONCOLOGY
9.5.1. Overview
9.5.2. Oncology Market Forecast and Analysis
9.6. CNS CONDITIONS
9.6.1. Overview
9.6.2. CNS Conditions Market Forecast and Analysis
9.7. DIABETES
9.7.1. Overview
9.7.2. Diabetes Market Forecast and Analysis
9.8. OBESITY
9.8.1. Overview
9.8.2. Obesity Market Forecast and Analysis
9.9. OTHER INDICATIONS
9.9.1. Overview
9.9.2. Other Indications Market Forecast and Analysis

10. IN VIVO CRO MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America In Vivo CRO Market Overview
10.1.2 North America In Vivo CRO Market Forecasts and Analysis
10.1.3 North America In Vivo CRO Market Forecasts and Analysis - By Specimen Type
10.1.4 North America In Vivo CRO Market Forecasts and Analysis - By Study Type
10.1.5 North America In Vivo CRO Market Forecasts and Analysis - By Indication
10.1.6 North America In Vivo CRO Market Forecasts and Analysis - By Countries
10.1.6.1 United States In Vivo CRO Market
10.1.6.1.1 United States In Vivo CRO Market by Specimen Type
10.1.6.1.2 United States In Vivo CRO Market by Study Type
10.1.6.1.3 United States In Vivo CRO Market by Indication
10.1.6.2 Canada In Vivo CRO Market
10.1.6.2.1 Canada In Vivo CRO Market by Specimen Type
10.1.6.2.2 Canada In Vivo CRO Market by Study Type
10.1.6.2.3 Canada In Vivo CRO Market by Indication
10.1.6.3 Mexico In Vivo CRO Market
10.1.6.3.1 Mexico In Vivo CRO Market by Specimen Type
10.1.6.3.2 Mexico In Vivo CRO Market by Study Type
10.1.6.3.3 Mexico In Vivo CRO Market by Indication
10.2. EUROPE
10.2.1 Europe In Vivo CRO Market Overview
10.2.2 Europe In Vivo CRO Market Forecasts and Analysis
10.2.3 Europe In Vivo CRO Market Forecasts and Analysis - By Specimen Type
10.2.4 Europe In Vivo CRO Market Forecasts and Analysis - By Study Type
10.2.5 Europe In Vivo CRO Market Forecasts and Analysis - By Indication
10.2.6 Europe In Vivo CRO Market Forecasts and Analysis - By Countries
10.2.6.1 Germany In Vivo CRO Market
10.2.6.1.1 Germany In Vivo CRO Market by Specimen Type
10.2.6.1.2 Germany In Vivo CRO Market by Study Type
10.2.6.1.3 Germany In Vivo CRO Market by Indication
10.2.6.2 France In Vivo CRO Market
10.2.6.2.1 France In Vivo CRO Market by Specimen Type
10.2.6.2.2 France In Vivo CRO Market by Study Type
10.2.6.2.3 France In Vivo CRO Market by Indication
10.2.6.3 Italy In Vivo CRO Market
10.2.6.3.1 Italy In Vivo CRO Market by Specimen Type
10.2.6.3.2 Italy In Vivo CRO Market by Study Type
10.2.6.3.3 Italy In Vivo CRO Market by Indication
10.2.6.4 Spain In Vivo CRO Market
10.2.6.4.1 Spain In Vivo CRO Market by Specimen Type
10.2.6.4.2 Spain In Vivo CRO Market by Study Type
10.2.6.4.3 Spain In Vivo CRO Market by Indication
10.2.6.5 United Kingdom In Vivo CRO Market
10.2.6.5.1 United Kingdom In Vivo CRO Market by Specimen Type
10.2.6.5.2 United Kingdom In Vivo CRO Market by Study Type
10.2.6.5.3 United Kingdom In Vivo CRO Market by Indication
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific In Vivo CRO Market Overview
10.3.2 Asia-Pacific In Vivo CRO Market Forecasts and Analysis
10.3.3 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Specimen Type
10.3.4 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Study Type
10.3.5 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Indication
10.3.6 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Countries
10.3.6.1 Australia In Vivo CRO Market
10.3.6.1.1 Australia In Vivo CRO Market by Specimen Type
10.3.6.1.2 Australia In Vivo CRO Market by Study Type
10.3.6.1.3 Australia In Vivo CRO Market by Indication
10.3.6.2 China In Vivo CRO Market
10.3.6.2.1 China In Vivo CRO Market by Specimen Type
10.3.6.2.2 China In Vivo CRO Market by Study Type
10.3.6.2.3 China In Vivo CRO Market by Indication
10.3.6.3 India In Vivo CRO Market
10.3.6.3.1 India In Vivo CRO Market by Specimen Type
10.3.6.3.2 India In Vivo CRO Market by Study Type
10.3.6.3.3 India In Vivo CRO Market by Indication
10.3.6.4 Japan In Vivo CRO Market
10.3.6.4.1 Japan In Vivo CRO Market by Specimen Type
10.3.6.4.2 Japan In Vivo CRO Market by Study Type
10.3.6.4.3 Japan In Vivo CRO Market by Indication
10.3.6.5 South Korea In Vivo CRO Market
10.3.6.5.1 South Korea In Vivo CRO Market by Specimen Type
10.3.6.5.2 South Korea In Vivo CRO Market by Study Type
10.3.6.5.3 South Korea In Vivo CRO Market by Indication
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa In Vivo CRO Market Overview
10.4.2 Middle East and Africa In Vivo CRO Market Forecasts and Analysis
10.4.3 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Specimen Type
10.4.4 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Study Type
10.4.5 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Indication
10.4.6 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa In Vivo CRO Market
10.4.6.1.1 South Africa In Vivo CRO Market by Specimen Type
10.4.6.1.2 South Africa In Vivo CRO Market by Study Type
10.4.6.1.3 South Africa In Vivo CRO Market by Indication
10.4.6.2 Saudi Arabia In Vivo CRO Market
10.4.6.2.1 Saudi Arabia In Vivo CRO Market by Specimen Type
10.4.6.2.2 Saudi Arabia In Vivo CRO Market by Study Type
10.4.6.2.3 Saudi Arabia In Vivo CRO Market by Indication
10.4.6.3 U.A.E In Vivo CRO Market
10.4.6.3.1 U.A.E In Vivo CRO Market by Specimen Type
10.4.6.3.2 U.A.E In Vivo CRO Market by Study Type
10.4.6.3.3 U.A.E In Vivo CRO Market by Indication
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America In Vivo CRO Market Overview
10.5.2 South and Central America In Vivo CRO Market Forecasts and Analysis
10.5.3 South and Central America In Vivo CRO Market Forecasts and Analysis - By Specimen Type
10.5.4 South and Central America In Vivo CRO Market Forecasts and Analysis - By Study Type
10.5.5 South and Central America In Vivo CRO Market Forecasts and Analysis - By Indication
10.5.6 South and Central America In Vivo CRO Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil In Vivo CRO Market
10.5.6.1.1 Brazil In Vivo CRO Market by Specimen Type
10.5.6.1.2 Brazil In Vivo CRO Market by Study Type
10.5.6.1.3 Brazil In Vivo CRO Market by Indication
10.5.6.2 Argentina In Vivo CRO Market
10.5.6.2.1 Argentina In Vivo CRO Market by Specimen Type
10.5.6.2.2 Argentina In Vivo CRO Market by Study Type
10.5.6.2.3 Argentina In Vivo CRO Market by Indication

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. IN VIVO CRO MARKET, KEY COMPANY PROFILES
12.1. AMERICAN PRECLINICAL SERVICES, LLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CHARLES RIVER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. COVANCE INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GVK BIOSCIENCES PRIVATE LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. IRIS PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MELIOR DISCOVERY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PRONEXUS ANALYTICAL AB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SYNEOS HEALTH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WASHINGTON BIOTECHNOLOGY, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WUXI APPTEC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. American Preclinical Services, LLC.
2. Charles River
3. Covance Inc.
4. GVK Biosciences Private Limited
5. Iris Pharma
6. MELIOR DISCOVERY
7. Pronexus Analytical AB
8. Syneos Health
9. Washington Biotechnology, Inc.
10. WuXi AppTec